CDSCO IVD Registration Consultant | The Complete 2026 Guide for Diagnostics Manufacturers and Importers
CDSCO IVD Registration Consultant | The Complete 2026 Guide for Diagnostics Manufacturers and Importers - NKB Regovanta
Table of Contents
31 sections in this regulatory guidance
India buys most of its diagnostics from abroad, and almost every kit that enters the country needs a licence from one regulator. A CDSCO IVD registration consultant exists for exactly that reason. Figures shared by CDSCO at an India–Japan medical products regulatory symposium put Indian IVD imports near US$1.5 billion a year, with roughly 80% of reagents and kits coming from outside India. Yet many applications stall for months over avoidable paperwork errors. The cost is lost revenue, not lost science.
This guide explains what CDSCO IVD registration involves under the Medical Devices Rules, 2017, which forms apply to your product, how long approval takes, what it costs, and how to judge whether a consultant is worth hiring. You will also see the documents reviewers ask for first and the mistakes that trigger queries.
What Is a CDSCO IVD Registration Consultant?
A CDSCO IVD registration consultant is a regulatory specialist who prepares, files and defends diagnostic licence applications before the Central Drugs Standard Control Organisation. The role covers product classification, dossier building, portal submission, query response and post-approval maintenance.
In India, in-vitro diagnostics are regulated as medical devices under the Medical Devices Rules, 2017. CDSCO confirms that IVD kits, reagents, analysers and diagnostic software all sit inside this framework. The Central Licensing Authority handles imports of every risk class, plus manufacturing of Class C and Class D products.
A consultant does not replace your quality team. Instead, the consultant translates technical evidence your team already owns into the format CDSCO reviewers expect. That translation step is where most foreign manufacturers lose time.
Many firms discover this only after a first rejection. Therefore, engaging an experienced IVD registration consultant in India before the first filing usually costs less than fixing a stalled application later.
Why a CDSCO IVD Registration Consultant Matters More in 2026
Two shifts changed the stakes. First, since 1 October 2023 every notified device and diagnostic sold in India needs a valid licence, closing the old "non-notified" gap that many importers relied on. Second, CDSCO issued a draft guidance document for the import of in-vitro diagnostic medical devices in January 2026, setting out detailed checklists for import filings.
That draft guidance also splits the submission route. Commercial import applications in Form MD-14 go through the CDSCO MD Online Portal, while test licence applications in Form MD-16 move to the National Single Window System. A consultant who files on the wrong portal wastes a full review cycle.
The guidance sets indicative review targets of 270 days for a commercial import application and 30 days for a test licence. Meanwhile, CDSCO updated its list of laboratories approved for performance evaluation of IVDs in January and June 2026, which changes where your samples can be tested.
Table 1: Filing with an experienced consultant versus filing in-house without CDSCO experience
| Factor | With an experienced consultant | First-time in-house filing |
|---|---|---|
Classification | Checked against the published IVD classification list before filing | Often guessed from EU or FDA class |
Portal choice | MD Online for MD-14, NSWS for MD-16 | Frequent mis-routing and resubmission |
Query cycles | Usually one, answered inside the deadline | Two or more, each adding months |
Evidence gaps | Performance evaluation planned at the start | Discovered mid-review |
Realistic timeline | Close to the published target | Target plus six to twelve months |
How CDSCO Classifies IVDs: Class A to Class D
IVD risk classification decides everything downstream: which authority reviews your file, which form you use, what evidence you submit and what you pay. CDSCO publishes a four-tier scale.
Importantly, your Indian class may not match your CE mark or FDA class. CDSCO maintains its own published classification list, and a competent consultant checks your product against that list first rather than assuming equivalence.
Table 2: IVD risk classes and the licensing authority under the Medical Devices Rules, 2017
| Risk class | Risk level | Typical examples | Manufacturing authority | Import authority |
|---|---|---|---|---|
Class A | Low | Specimen receptacles, general reagents, culture media | State Licensing Authority | Central Licensing Authority |
Class B | Low–moderate | Self-test pregnancy kits, clinical chemistry reagents | State Licensing Authority | Central Licensing Authority |
Class C | Moderate–high | Blood glucose self-testing, PSA, cancer markers | Central Licensing Authority | Central Licensing Authority |
Class D | High | HIV, HBsAg, HCV, blood grouping reagents | Central Licensing Authority | Central Licensing Authority |
If your product does not appear in the published list, CDSCO allows a classification request through its portal. A CDSCO IVD registration consultant typically files this first, because an unclassified product cannot be licensed.
What Does a CDSCO IVD Registration Consultant Actually Do?
The work splits into four phases. Each phase has its own failure mode, so treat them separately when you scope a contract.
Phase 1: Strategy and classification
The consultant confirms the risk class, checks whether a predicate exists in India, and picks the pathway. A product with no Indian predicate is treated as a new IVD and follows a longer route through clinical performance evaluation under Forms MD-24 and MD-25.
Phase 2: Dossier preparation
Next comes the Device Master File and Plant Master File, built to CDSCO expectations rather than EU technical documentation habits. The consultant maps your existing ISO 13485 evidence into the Indian format and flags gaps early.
Phase 3: Filing and query management
The consultant submits through the correct portal, tracks the application and drafts responses when CDSCO raises queries. Query deadlines are short, and a missed reply can close the file.
Phase 4: Post-approval lifecycle
Finally, licences need endorsements for new products, retention before the five-year mark, and change notifications. Good in-vitro diagnostic regulatory services in India cover this phase rather than stopping at grant.
CDSCO Forms Every IVD Company Should Recognise
Form numbers are the working language of Indian device regulation. Consequently, a consultant who cannot name the right form on a first call is a warning sign.
Table 3: Core CDSCO application and licence forms for in-vitro diagnostics
| Purpose | Application form | Licence or permission |
|---|---|---|
Import for commercial sale (all classes) | Form MD-14 | Form MD-15 |
Import for test, evaluation or demonstration | Form MD-16 | Form MD-17 |
Manufacture Class A or Class B | Form MD-3 | Form MD-5 |
Manufacture Class C or Class D | Form MD-7 | Form MD-9 |
Loan licence, Class C or Class D | Form MD-8 | Form MD-10 |
Clinical performance evaluation of a new IVD | Form MD-24 | Form MD-25 |
Import or manufacture of a new IVD | Form MD-28 | Form MD-29 |
Registration of an IVD testing laboratory | Form MD-39 | Form MD-40 |
Registration certificate for the applicant | — | Form MD-42 |
Two of these deserve attention. The import licence in Forms MD-14 and MD-15 is what lets you sell commercially, while the test licence for IVD devices in Forms MD-16 and MD-17 only permits evaluation quantities. Shipping commercial stock on a test licence is a compliance breach.
Performance Evaluation: The Step That Delays Most IVD Approvals
Under the Fourth Schedule of the Medical Devices Rules, 2017, applicants submit a manufacturer performance evaluation report with the application. However, for Class B, C and D diagnostics the licensing authority may demand an independent report from a recognised laboratory.
CDSCO's guidance on performance evaluation of in-vitro diagnostic medical devices lists the categories that usually attract this demand: HIV, HBV, HCV, syphilis, blood grouping reagents, malaria, dengue, tuberculosis, cancer markers, influenza and other life-threatening infections.
For several of these, the National Institute of Biologicals at Noida acts as the nodal testing facility, alongside ICMR institutes and selected accredited hospitals. Sample panels, shipping, cold chain and laboratory queues all take real calendar time.
Therefore, a consultant should book laboratory slots in parallel with dossier writing, not after filing. Treating evaluation as a sequential step is the single most common reason an IVD approval slips past a year.
Documents Your CDSCO IVD Registration Consultant Will Request
The checklist annexed to CDSCO's Form MD-14 import licence guidance runs to dozens of line items. In practice, the following set carries most of the review weight.
Start with corporate papers: the applicant's wholesale licence, the Indian Authorised Agent appointment, a notarised power of attorney, and the registration certificate in Form MD-42. Foreign documents generally need authentication by an Indian mission abroad or a first-class magistrate in India.
Then come product papers: the Device Master File, the Plant Master File, a valid ISO 13485 certificate, a free sale certificate or marketing authorisation from the country of origin, labels, instructions for use, stability data and the performance evaluation report.
Finally, add the evidence that supports claims: analytical sensitivity and specificity, cross-reactivity, interference studies, lot-to-lot reproducibility and shelf-life justification. A consultant who asks for these on day one is doing the job properly.
Timelines and Government Fees for CDSCO IVD Registration
Government fees are set in the Medical Devices Rules and charged per site plus per distinct product. Consultant fees sit on top and vary with scope.
Table 4: Indicative government fees and review timelines for IVD applications
| Application | Government fee | Indicative timeline |
|---|---|---|
Import licence, Class A or B IVD | US$1,000 per site plus US$10 per product | 6–9 months |
Import licence, Class C or D IVD | US$3,000 per site plus US$500 per product | 9–12 months |
Import test licence (Form MD-16) | Prescribed test licence fee | About 30 days |
Manufacturing licence, Class A or B | State fee per site and per product | 3–6 months |
Manufacturing licence, Class C or D | Central fee per site and per product | 6–12 months |
Fee slabs and endorsement rules change, and CDSCO publishes clarifications through its IVD FAQ addendum. Always confirm current slabs before budgeting a portfolio filing.
Importers and Indian Manufacturers Follow Different Routes
The pathway depends on where the product is made, not on who sells it. Both routes converge on the same evidence standards, yet the paperwork and the reviewing authority differ.
Foreign manufacturers and importers
A foreign manufacturer cannot file directly. You appoint an Indian Authorised Agent who holds a wholesale licence and files Form MD-14 in its own name. Choose that agent carefully, because the licence is granted to the agent, and changing agents later means fresh filings. For a product with no Indian predicate, add the import authorisation route for novel IVDs.
Indian manufacturers
Domestic manufacturers file with the State Licensing Authority for Class A and B, and with CDSCO for Class C and D through Forms MD-7 and MD-9. Expect a joint audit of the site. Before commercial manufacture, most firms also need a CDSCO test licence to make validation batches legally.
How to Choose the Right CDSCO IVD Registration Consultant
Diagnostics are not general medical devices, and a firm that files orthopaedic implants will not necessarily understand sensitivity panels. Use the following checks before you sign.
Ask for IVD-specific references, not a combined device and pharma client list, and request the risk classes they have actually cleared.
Confirm they have managed at least one Class C or Class D file end to end, including an independent performance evaluation.
Check whether they will act as your Indian Authorised Agent or work alongside one you appoint, and get that choice in writing.
Require a written gap assessment of your existing dossier before any filing fee is paid.
Agree query response ownership, turnaround times and who drafts the technical answers.
Confirm post-approval scope covers endorsements, licence retention and change notifications.
Compare total cost of ownership across five years rather than the headline filing fee.
A credible CDSCO IVD registration consultant will answer all seven without hesitation and will tell you plainly when your evidence is not ready.
Common Mistakes That Delay CDSCO IVD Approvals
CDSCO has stated that technical errors in submissions are a leading cause of delay. The same handful of errors recurs across applicants.
Teams copy their EU risk class into the Indian application without checking the CDSCO list. They submit a free sale certificate that is expired, unnotarised or not authenticated. They file one application covering several manufacturing sites when each site needs its own licence.
Labels create their own trouble. Indian labelling requirements differ from EU and US rules, and reviewers check them closely. Similarly, instructions for use that reference unapproved claims will attract a query every time.
Finally, firms underestimate query deadlines. CDSCO expects a complete technical reply within the stated window, and partial answers restart the clock. Strong medical device documentation practice prevents most of this.
Keeping Your IVD Licence Valid After Approval
An import licence in Form MD-15 does not expire on a fixed date in the way older registrations did. Instead, it stays valid subject to a retention application and fee before the five-year mark from the base licence date.
Miss that window and you face late fees or, worse, a lapsed licence that halts shipments. CDSCO has issued a specific circular on retention of licences and certificates under the Medical Devices Rules, 2017.
Adding products to an existing licence happens through endorsement rather than a fresh application, which is cheaper and faster. However, each new manufacturing site still needs its own licence.
Beyond that, holders of new-IVD permissions submit periodic safety update reports, and all licence holders must report adverse events and field safety actions. Treat the grant as the start of the compliance cycle, not the end.
What Regulatory Professionals Discuss on Reddit
Practitioners trade practical notes in public forums, and those threads are useful for sanity-checking timelines a vendor quotes you. Discussions on r/regulatoryaffairs regularly cover emerging-market registration strategy, authorised representative arrangements and dossier formats across jurisdictions.
Meanwhile, r/medicaldevices carries threads on classification disputes, predicate selection and the realities of working with in-country agents. For narrower questions, a Reddit search for CDSCO discussions surfaces recent posts and comments from people filing right now.
Treat these as directional, not authoritative. Community advice reflects individual experience, whereas CDSCO guidance documents and the Medical Devices Rules, 2017 remain the only binding references.
Frequently Asked Questions About CDSCO IVD Registration Consultants
What is a CDSCO IVD registration consultant?
A CDSCO IVD registration consultant is a regulatory professional who manages diagnostic product approvals in India from classification to licence grant. The work includes confirming the risk class against the CDSCO list, compiling the Device Master File and Plant Master File, arranging performance evaluation where required, filing on the correct government portal, and answering reviewer queries. Many consultants also act as, or coordinate with, the Indian Authorised Agent who legally holds the import licence.
How long does CDSCO IVD registration take?
Plan for six to twelve months for a commercial import licence in Form MD-15, depending on risk class and evidence quality. CDSCO's 2026 draft import guidance indicates a 270-day review target for Form MD-14 applications and roughly 30 days for a Form MD-16 test licence. Independent performance evaluation can add three to nine months on top, which is why a CDSCO IVD registration consultant books laboratory slots in parallel with dossier preparation rather than afterwards.
How much does a CDSCO IVD registration consultant cost?
Consultant fees sit separately from government fees. Government fees for an import licence run roughly US$1,000 per site plus US$10 per product for Class A and B diagnostics, and about US$3,000 per site plus US$500 per product for Class C and D. Professional fees vary with portfolio size, number of manufacturing sites and whether performance evaluation coordination is included. Always ask for a fixed scope and a separate line item for laboratory testing costs.
What is the difference between Form MD-15 and Form MD-17?
Form MD-15 is the commercial import licence that allows you to sell a diagnostic in India, granted on an application in Form MD-14. Form MD-17 is a test licence granted on Form MD-16, and it only permits import of limited quantities for testing, evaluation, demonstration, training or clinical performance evaluation. You cannot sell stock imported under Form MD-17. A CDSCO IVD registration consultant will usually sequence the test licence first, then the commercial licence.
Do I still need CDSCO approval if my IVD has CE marking or FDA clearance?
Yes. Approval elsewhere supports your file but does not replace an Indian licence. CDSCO applies its own classification list, its own labelling rules and its own evidence expectations under the Medical Devices Rules, 2017. Reference-country approval can reduce clinical requirements for some products, yet the import licence remains mandatory. Many applicants also find their Indian risk class differs from the EU class, which changes the form, the fee and the reviewing authority.
Can a foreign manufacturer apply to CDSCO directly?
No. A foreign manufacturer must appoint an Indian Authorised Agent holding a valid wholesale licence, who then files in its own name under a notarised power of attorney. Because the licence attaches to that agent, changing agents later means re-filing. Select the agent on regulatory capability and commercial neutrality, not only on distribution reach.
Questions & Answers
Who regulates IVD kits in India?
The Central Drugs Standard Control Organisation regulates IVD kits in India under the Medical Devices Rules, 2017. The Central Licensing Authority handles imports of all risk classes and manufacturing of Class C and Class D products, while State Licensing Authorities handle Class A and Class B manufacturing.
Which form is used for IVD import licence in India?
You apply in Form MD-14 and receive the import licence in Form MD-15. Applications are filed by an Indian Authorised Agent through the CDSCO MD Online Portal. For test or evaluation imports, you use Form MD-16 and receive Form MD-17 instead.
Is a performance evaluation report mandatory for IVD registration?
A manufacturer performance evaluation report is always submitted. Additionally, the licensing authority may require an independent report from a recognised laboratory for Class B, C and D diagnostics, especially for HIV, hepatitis, blood grouping, malaria, dengue, tuberculosis and cancer markers.
How do I check my IVD risk class in India?
Check your product against the IVD classification list published on the CDSCO website rather than assuming your EU or FDA class applies. If the product is not listed, you can request a classification decision through the CDSCO portal before filing the licence application.
Choosing a CDSCO IVD registration consultant is really a decision about evidence, sequencing and accountability. The firms that clear Indian approvals quickly are the ones that classify correctly on day one, plan performance evaluation before filing, and answer queries with complete technical arguments instead of holding replies. If you are mapping a route for a diagnostic portfolio, start with in-vitro diagnostic regulatory services in India and review the wider medical device licensing and regulatory approvals in India framework alongside it. A well-briefed CDSCO IVD registration consultant turns a twelve-month unknown into a scheduled project with a date your commercial team can plan against.
Frequently Asked Questions
NKB Regulatory Experts
Verified Regulatory ExpertM.Pharm, RAC (Global Regulatory Affairs Certified)
Senior Regulatory Affairs & Quality Assurance Specialists at NKB Regovanta Solutions Pvt. Ltd., guiding MedTech manufacturers worldwide across CDSCO, US FDA, EU MDR, and ISO 13485 compliance.
Facing medical device compliance bottlenecks or Notified Body review findings?
NKB Regovanta conducts thorough regulatory gap assessments, dossier remediation, and health authority liaison to secure market approvals with confidence.